MDxHealth (MDXH) Gross Profit (2021 - 2026)

MDxHealth has reported Gross Profit for 6 years, with the latest figure at $16.6 million in Q1 2026.

• Quarterly Gross Profit rose 7.16% year-over-year to $16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.8 million (up 77.21% YoY) and the FY2025 annual result came in at $69.6 million, up 26.28% from the prior year.
• Gross Profit retreated to $16.6 million in Q1 2026 per MDXH's latest filing, from $18.7 million in the prior quarter.
• Over five years, Gross Profit peaked at $50.9 million in Q3 2025 and troughed at -$2.8 million in Q2 2022.
• A 5-year average of $13.6 million and a median of $12.7 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2023 and 2026: Gross Profit soared 452.1% in 2023, then rose 7.16% in 2026.
• Over 5 years, Gross Profit stood at $7.2 million in 2022, then surged by 75.4% to $12.7 million in 2023, then climbed by 22.46% to $15.5 million in 2024, then advanced by 20.43% to $18.7 million in 2025, then dropped by 11.09% to $16.6 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $16.6 million, $18.7 million, and $50.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.